Think Eli Lilly's Stock Is Expensive? Here's Why Selling It Now Could Be a Huge Mistake
The recent surge has been due to the tremendous growth Lilly has achieved due to its highly popular GLP-1 drugs, including ...
Biogen Q4 Earnings Review: Why I'm Calling Time On This 'Powder Puff' Pharma
Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...
Pharma-Bio Serv (OTCMKTS:PBSV) Share Price Passes Above 200 Day Moving Average – Here’s Why
Shares of Pharma-Bio Serv, Inc. (OTCMKTS:PBSV – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.58 and traded as high ...
Verona Pharma (NASDAQ:VRNA) Price Target Raised to $72.00
Verona Pharma (NASDAQ:VRNA – Free Report) had its price target hoisted by Canaccord Genuity Group from $44.00 to $72.00 in a research note published on Wednesday,Benzinga reports. They currently have ...
Agios Pharmaceuticals: Liver Toxicity Issues May Threaten Thalassemia Approval (Rating Downgrade)
Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.
JD Supra20h
Mintz IRA Update — From the Desk of ML Strategies: The Medicare Drug Price Negotiation Program Under the Second Trump Administration
The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...
Urban Milwaukee20h
Senator Baldwin Introduces Bill to Cap Prescription Drug Costs
The Capping Prescription Costs Act would cap annual out-of-pocket prescription drug costs per year at $2,000 for individuals ...
JD Supra20h
Mintz IRA Update — The Future of the Medicare Drug Price Negotiation Program
The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...
Travere Therapeutics (TVTX): Among The Small–Cap Stocks Insiders Are Selling Recently
We recently published a list of 10 Small–Cap Stocks Insiders Are Selling Recently. In this article, we are going to take a look at where Travere Therapeutics, Inc.